He maha ngā wā ka whakamahia te INR hei ine i te pānga o ngā rongoā ārai toto ā-waha i roto i ngā mate thromboembolic. Ka kitea te INR roa i roto i ngā rongoā ārai toto ā-waha, te DIC, te korenga o te huaora K, te hyperfibrinolysis me ētahi atu. He maha ngā wā ka kitea te INR poto i roto i ngā āhua toto totoka nui me ngā mate toto totoka. Ko te INR, e mōhiotia ana ko te International Normalized Ratio, tētahi o ngā tūemi whakamātautau mahi toto totoka. Ko te INR e hangai ana i te PT reagent hei whakatikatika i te International Sensitivity Index me te tatau i te hua mā roto i ngā tātai e pā ana. Mena he tino tiketike te INR, tera pea ka puta he toto kore e taea te whakahaere. Ka taea e te INR te aroturuki me te whakamahi i te pānga o ngā rongoā ārai toto. I te nuinga o te wā, ka whakamahia te rongoā ārai toto warfarin, ā, me aroturuki tonu te INR. Me mōhio koe mena ka whakamahia te warfarin, me aroturuki tonu te INR. Me tango warfarin ā-waha ngā tūroro e pāngia ana e te thrombosis venous, ā, me pupuri te uara INR ki te 2.0-2.5. Mō ngā tūroro e pāngia ana e te atrial fibrillation, ko te uara inr o te warfarin ā-waha ka puritia i waenga i te 2.0-3.0. Ahakoa te nui o te toto e kore e taea te whakahaere mēnā he nui ake i te 4.0, kāore pea ngā toto e taea te whakaheke toto ina he nui ake i te 2.0.
Whakaaro: me haere tonu ki te hōhipera noa mō ngā tirotiro hauora, me te whakarongo ki ngā whakaritenga a te tākuta ngaio.
He tohunga a Beijing Succeeder ki ngā hua tātaritanga mō te thrombosis me te hemostasis mō te mākete o te ao.
Hei tētahi o ngā waitohu matua i te mākete tātaritanga o Haina mō te Thrombosis me te Hemostasis. He maha ngā rōpū wheako o SUCCEEDER i roto i te R&D, te Hanga, te Hokohoko me te Ratonga e tuku ana i ngā tātaritanga toto toto me ngā matū tauhohenga, ngā tātaritanga toto toto, ngā tātaritanga ESR me te HCT, ngā tātaritanga whakahiato pereti toto me te Tiwhikete ISO13485 CE me te rārangi FDA.
Kāri pakihi
WeChat Hainamana